KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amneal Pharmaceuticals (AMRX) Other Non Operating Income: 2016-2024

Historic Other Non Operating Income for Amneal Pharmaceuticals (AMRX) over the last 9 years, with Dec 2024 value amounting to $11.8 million.

  • Amneal Pharmaceuticals' Other Non Operating Income fell 1480.83% to -$31.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$16.7 million, marking a year-over-year increase of 54.45%. This contributed to the annual value of $11.8 million for FY2024, which is 128.87% up from last year.
  • Amneal Pharmaceuticals' Other Non Operating Income amounted to $11.8 million in FY2024, which was up 128.87% from -$40.8 million recorded in FY2023.
  • Amneal Pharmaceuticals' Other Non Operating Income's 5-year high stood at $18.5 million during FY2022, with a 5-year trough of -$40.8 million in FY2023.
  • Over the past 3 years, Amneal Pharmaceuticals' median Other Non Operating Income value was $11.8 million (recorded in 2024), while the average stood at -$3.5 million.
  • Its Other Non Operating Income has fluctuated over the past 5 years, first skyrocketed by 429.50% in 2020, then plummeted by 321.00% in 2023.
  • Amneal Pharmaceuticals' Other Non Operating Income (Yearly) stood at $16.4 million in 2020, then declined by 6.24% to $15.3 million in 2021, then increased by 20.44% to $18.5 million in 2022, then plummeted by 321.00% to -$40.8 million in 2023, then soared by 128.87% to $11.8 million in 2024.